Tinea Corporis, Cruris & Pedis References

Last updated: 21 April 2026
Reviewed by
  1. Andrews MD, Burns M. Common tinea infections in children. Am Fam Physician. 2008 May;77(10):1415-1420. PMID: 18533375
  2. Hainer BL. Dermatophyte infections. Am Fam Physician. 2003 Jan;67(1):101-108. PMID: 12537173
  3. Moossavi M, Bagheri B, Scher RK. Systemic antifungal therapy. Dermatol Clin. 2001 Jan;19(1):35-52. PMID: 11155585
  4. Vander-Straten MR, Hossain MA, Ghannoum MA. Cutaneous infections: dermatophytosis, onychomycosis and tinea versicolor. Infect Dis Clin N Am. 2003 Mar;17(1):87-112. PMID: 12751262
  5. Weinstein A, Berman B. Topical treatment of common superficial tinea infections. Am Fam Physician. 2002 May;65(10):2095-2102. PMID: 12046779
  6. Rupke SJ. Fungal skin disorders. Prim Care. 2000 Jun;27(2):407-421. PMID: 10815051
  7. Gilbert DN, Moellering RC, Eliopoulos GM, et al. The Sanford Guide to Antimicrobial Therapy. 37th ed. Sperryville, VA: Antimicrobial Therapy Inc; 2007.
  8. Habif TP. Superficial fungal infections. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 4th ed. Pennsylvania (PA): Mosby, Elsevier; 2004:409-439.
  9. MedWorm http://www.medworm.com/rss/index.php/Dermatology/12/ http://www.medworm.com/rss/medicalfeeds/specialities/Dermatology-News.xml
  10. MedWorm http://www.medworm.com/rss/index.php/Pediatrics/33/ http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics-News.xml
  11. Ely JW, Rosenfeld S, Seabury Stone M. Diagnosis and management of tinea infections. Am Fam Physician. 2014 Nov;90(10):702-710. https://www.aafp.org/. PMID: 25403034
  12. El-Gohary M, van Zuuren EJ, Fedorowicz Z, et al. Topical antifungal treatments for tinea cruris and tinea corporis (Review). Cochrane Database Syst Rev. 2014 Aug;8:CD009992. doi: 10.1002/14651858.CD009992.pub2. PMID: 25090020
  13. Primary Care Dermatology Society (PCDS). Tinea corporis (body), cruris (groin) and incognito (steroid exacerbated). PCDS. http://www.pcds.org.uk/. Jan 2017. Accessed 19 Apr 2018.
  14. Sahoo AK, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review. Indian Dermatol Online J. 2016 Mar;7(2):77-86. doi: 10.4103/2229-5178.178099. PMID: 27057486
  15. Shoham S, Groll AH, Walsh TJ. Antifungal agents. In: Cohen J. Infectious Diseases. 3rd ed. Philadelphia, PA: Mosby Elsevier; 2010:1477-1489.
  16. Goldstein AO, Goldstein BG. Dermatophyte (tinea) infections. UpToDate. https://www.uptodate.com. 02 Jan 2026. Accessed 24 Sep 2024.
  17. Leung AK, Lam JM, Leong KF, et al. Tinea corporis: an updated review. Drugs Context. 2020 Jul;20(9):5-6. doi: 10.7573/dic.2020-5-6. PMID: 32742295
  18. Nigam PK, Syed HA, Saleh D. Tinea pedis. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan.
  19. Pippin MM, Madden ML, Das M. Tinea cruris. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan.
  20. Yee G, Syed HA, Al Aboud AM. Tinea corporis. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan.
  21. Verma S, Hefferman M. Superficial fungal infection: dermatophytosis, onychomycosis, tinea nigra, piedra. In: Goldsmith LA, Katz SI, Gilchrest BA, et al. Fitzpatrick’s Dermatology in General Medicine. 8th ed. New York: McGraw-Hill; 2012.
  22. Caplan AS, Gold JAW, Smith DJ, et al. Diagnosis and management of tinea infections. Am Fam Physician. 2025 Oct;112(4):382-392. Accessed 25 May 2026. PMID: 41118183
  23. Martinez-Rossi NM, Peres NTA, Bitencourt TA, et al. State-of-the-art dermatophyte infections: epidemiological aspects, pathophysiology, and resistance mechanisms. J Fungi (Basel). 2021 Aug;7(8). doi: 10.3390/jof7080629. PMID: 34436168
  24. Petrucelli MF, Abreu MH, Cantelli BAM, et al. Epidemiology and diagnostic perspectives of dermatophytoses. J Fungi (Basel). 2020 Nov;6(4). doi: 10.3390/jof6040310. PMID: 33238603
  25. Watkins RR, David MZ. Approach to the patient with a skin and soft tissue infection. Infect Dis Clin North Am. 2021 Mar;35(1):1-48. doi: 10.1016/j.idc.2020.10.011. PMID: 33494872